您使用提示模式 关闭

XBI - SPDR S&P Biotech ETF (USD) (US78464A8707)

The comparsion limit has been reached: only 5 tools has been added. To add a new one, please remove one of the existing tools.

使用 Cbonds Watchlist 查找、保存和跟踪投资工具

有了 Cbonds Watchlist，您可以随时了解投资信息，做出明智决策！

Watchlist
需要 访问

全选 清除所有
 
(%)
US78464A8707
XBI ISIN
交易所交易基金 (ETF)
基金类型
SPDR State Street Global Advisors
提供商
165,68 USD
每股资产净值 | 2026-08-21
2006-01-31
成立日期
4 每年的次数
股息的支付
CEOILS
CFI
XBI
代码
Formed
Status
Equity
投资项目
Biotech
部门
USA
地区分布
S&P Biotechnology Select Industry Index
基准
0.35 %
总成本比率
11.394,92 百万 USD
基金资产总量 | 2026-08-20
否
UCITS
1 / 3 (11/09/2015)
拆分

收益率 在 2026-08-21, NYSE Arca

  • YTD
    5,06 %
  • 1M
    -7,93 %
  • 3M
    1,65 %
  • 6M
    11,2 %
  • 1Y
    62,15 %
  • 3Y
    51,47 %
  • 5Y
    0,91 %
  • 10Y
    143,19 %
按交换价格计算，包括收入支付

最新数据在
添加比较项目
从
至
ADD-IN
Cbonds 加载项 API
债券数据 API

报价 (XBI)

探索最全面的数据库

1 000 000

债券

100 000

股票

175 910

ETF & Funds

8万

指数

以最有效的方式跟踪您的投资组合

  • 债券筛选器
  • 观察列表
  • Excel 附加组件
请求访问

价格动态的变化

Fund profile

The SPDR S&P Biotech ETF seeks to replicate as closely as possible the price and yield performance of the S&P Biotechnology Select Industry Index by investing in a portfolio comprised primarily of U.S. companies in the biotechnology sector

XBI profile

The SPDR S&P Biotech ETF (USD) is a(n) Equity Exchange Traded Funds (ETF) seeks to invest in Biotech sector located in USA. The SPDR State Street Global Advisors fund’s base currency is USD and the share class was registered 31.01.2006 with unique ISIN - US78464A8707. Main exchange is NYSE Arca and ticker symbol is XBI. The total expense ratio is 0.35%. The SPDR S&P Biotech ETF (USD) pays dividends 4 time(s) per year.

结构 XBI 在 2026-08-20

下载结构至 Excel 文档
证券 值
MODERNA INC 2,65%
TWIST BIOSCIENCE CORP 1,84%
ORUKA THERAPEUTICS INC 1,5%
APOGEE THERAPEUTICS INC 1,49%
KYMERA THERAPEUTICS INC 1,42%
PRAXIS PRECISION MEDICINES I 1,39%
HALOZYME THERAPEUTICS INC 1,38%
NATERA INC 1,37%
REVOLUTION MEDICINES INC 1,34%
SPYRE THERAPEUTICS INC 1,31%
DIANTHUS THERAPEUTICS INC 1,31%
PROTAGONIST THERAPEUTICS INC 1,3%
CG ONCOLOGY INC 1,29%
TRAVERE THERAPEUTICS INC 1,26%
REGENERON PHARMACEUTICALS 1,26%
INSMED INC 1,25%
VAXCYTE INC 1,24%
IOVANCE BIOTHERAPEUTICS INC 1,2%
ROIVANT SCIENCES LTD 1,19%
ERASCA INC 1,17%
AMGEN INC 1,17%
RHYTHM PHARMACEUTICALS INC 1,16%
SCHOLAR ROCK HOLDING CORP 1,15%
RELAY THERAPEUTICS INC 1,14%
VERTEX PHARMACEUTICALS INC 1,13%
VIKING THERAPEUTICS INC 1,13%
ARROWHEAD PHARMACEUTICALS IN 1,13%
BRIDGEBIO PHARMA INC 1,13%
INCYTE CORP 1,11%
BIOMARIN PHARMACEUTICAL INC 1,1%
GILEAD SCIENCES INC 1,08%
UNIQURE NV 1,08%
CRISPR THERAPEUTICS AG 1,08%
SELLAS LIFE SCIENCES GROUP I 1,07%
ABBVIE INC 1,06%
ACADIA PHARMACEUTICALS INC 1,06%
CYTOKINETICS INC 1,05%
IMMUNOVANT INC 1,05%
COGENT BIOSCIENCES INC 1,03%
GRAIL INC 1,02%
BIOGEN INC 1,01%
MADRIGAL PHARMACEUTICALS INC 1,01%
ALKERMES PLC 1%
TG THERAPEUTICS INC 0,99%
DYNE THERAPEUTICS INC 0,99%
KRYSTAL BIOTECH INC 0,99%
MIRUM PHARMACEUTICALS INC 0,95%
CELCUITY INC 0,94%
EXELIXIS INC 0,93%
IMMUNITYBIO INC 0,9%
VIRIDIAN THERAPEUTICS INC 0,88%
BEAM THERAPEUTICS INC 0,88%
PTC THERAPEUTICS INC 0,88%
UNITED THERAPEUTICS CORP 0,88%
NEUROCRINE BIOSCIENCES INC 0,87%
ULTRAGENYX PHARMACEUTICAL IN 0,85%
SUMMIT THERAPEUTICS INC 0,85%
BIOCRYST PHARMACEUTICALS INC 0,85%
IDEAYA BIOSCIENCES INC 0,83%
DENALI THERAPEUTICS INC 0,8%
SAREPTA THERAPEUTICS INC 0,79%
IMMUNOME INC 0,77%
VERA THERAPEUTICS INC 0,76%
CELLDEX THERAPEUTICS INC 0,74%
IONIS PHARMACEUTICALS INC 0,73%
ALNYLAM PHARMACEUTICALS INC 0,72%
ARCUS BIOSCIENCES INC 0,7%
ADMA BIOLOGICS INC 0,7%
DISC MEDICINE INC 0,69%
RECURSION PHARMACEUTICALS A 0,68%
ARCUTIS BIOTHERAPEUTICS INC 0,68%
MINERALYS THERAPEUTICS INC 0,67%
INTELLIA THERAPEUTICS INC 0,66%
SYNDAX PHARMACEUTICALS INC 0,64%
TANGO THERAPEUTICS INC 0,62%
AGIOS PHARMACEUTICALS INC 0,62%
NURIX THERAPEUTICS INC 0,61%
HYPERLIQUID STRATEGIES 0,59%
NOVAVAX INC 0,58%
VERACYTE INC 0,57%
KODIAK SCIENCES INC 0,55%
PALVELLA THERAPEUTICS INC 0,54%
CAREDX INC 0,49%
PRECIGEN INC 0,49%
XENCOR INC 0,48%
BIOHAVEN LTD 0,47%
CULLINAN THERAPEUTICS INC 0,47%
VERICEL CORP 0,46%
STOKE THERAPEUTICS INC 0,46%
ABSCI CORP 0,44%
VIR BIOTECHNOLOGY INC 0,42%
ORIC PHARMACEUTICALS INC 0,42%
ANAPTYSBIO INC 0,41%
ZENAS BIOPHARMA INC 0,39%
CORVUS PHARMACEUTICALS INC 0,39%
VOR BIOPHARMA INC 0,37%
AVALO THERAPEUTICS INC 0,37%
INHIBRX BIOSCIENCES INC 0,37%
FIRST TRACKS BIOTHERAPEUTICS 0,36%
REPLIMUNE GROUP INC 0,36%
显示所有 隐藏
Other - %

其他 ETF 和基金提供商

相关 ETF 和基金

  • {{ item.etf.ttl }}
    {{ item.nav_usd }} 百万
    资产净值
    {{ item.expense_ratio }}
    总成本比率
你必须 注册 才能获得访问权